These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34193687)
1. Dexmedetomidine Reduces the Lidocaine-Induced Neurotoxicity by Inhibiting Inflammasome Activation and Reducing Pyroptosis in Rats. Ding XD; Cao YY; Li L; Zhao GY Biol Pharm Bull; 2021; 44(7):902-909. PubMed ID: 34193687 [TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Sun YB; Zhao H; Mu DL; Zhang W; Cui J; Wu L; Alam A; Wang DX; Ma D Cell Death Dis; 2019 Feb; 10(3):167. PubMed ID: 30778043 [TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine exerts a protective effect on ischemic brain injury by inhibiting the P2X7R/NLRP3/Caspase-1 signaling pathway. Sun K; Zhang J; Yang Q; Zhu J; Zhang X; Wu K; Li Z; Xie W; Luo X Brain Res Bull; 2021 Sep; 174():11-21. PubMed ID: 33991606 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats. Zhong Y; Li YP; Yin YQ; Hu BL; Gao H Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine ameliorates lidocaine-induced spinal neurotoxicity via inhibiting glutamate release and the PKC pathway. Xu H; Zhao B; She Y; Song X Neurotoxicology; 2018 Dec; 69():77-83. PubMed ID: 30240660 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine's protective mechanism against hyperoxic injury in neonatal rats. Zhang QY; Feng Y; Cai H J Physiol Pharmacol; 2024 Jun; 75(3):. PubMed ID: 39042394 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. Gao J; Sun Z; Xiao Z; Du Q; Niu X; Wang G; Chang YW; Sun Y; Sun W; Lin A; Bresnahan JC; Maze M; Beattie MS; Pan JZ Br J Anaesth; 2019 Dec; 123(6):827-838. PubMed ID: 31623841 [TBL] [Abstract][Full Text] [Related]
8. Melatonin ameliorates bupivacaine-induced spinal neurotoxicity in rats by suppressing neuronal NLRP3 inflammasome activation. Lai J; Ji JM; Chen MY; Luo YP; Yu Y; Zhou G; Wei LL; Huang LS; Liu JC Neurosci Lett; 2022 Feb; 772():136472. PubMed ID: 35065245 [TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages. Chen Y; Huang Y; Xiong B; Luo H; Song X Gene; 2020 Oct; 758():144973. PubMed ID: 32707303 [TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats. Yu W; Lyu J; Jia L; Sheng M; Yu H; Du H Oxid Med Cell Longev; 2020; 2020():7385458. PubMed ID: 34493950 [TBL] [Abstract][Full Text] [Related]
11. Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro. Ma DC; Zhang NN; Zhang YN; Chen HS J Ethnopharmacol; 2021 Apr; 270():113776. PubMed ID: 33421597 [TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine reduces hippocampal microglia inflammatory response induced by surgical injury through inhibiting NLRP3. Peng J; Zhang P; Zheng H; Ren YQ; Yan H Chin J Traumatol; 2019 Jun; 22(3):161-165. PubMed ID: 31056470 [TBL] [Abstract][Full Text] [Related]
13. Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Liu Z; Tu K; Zou P; Liao C; Ding R; Huang Z; Huang Z; Yao X; Chen J; Zhang Z Int Immunopharmacol; 2023 May; 118():110103. PubMed ID: 37001385 [TBL] [Abstract][Full Text] [Related]
14. Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats. Dai W; Wang X; Teng H; Li C; Wang B; Wang J Int Immunopharmacol; 2019 Jan; 66():215-223. PubMed ID: 30472522 [TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a. Zheng LN; Guo FQ; Li ZS; Wang Z; Ma JH; Wang T; Wei JF; Zhang WW Hum Exp Toxicol; 2020 Sep; 39(9):1213-1223. PubMed ID: 32228195 [TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats. Fu C; Dai X; Yang Y; Lin M; Cai Y; Cai S Mol Med Rep; 2017 Jan; 15(1):131-138. PubMed ID: 27959438 [TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine Ameliorates Post-CPB Lung Injury in Rats by Activating the PI3K/Akt Pathway. Li J; Dou X; Li D; He M; Han M; Zhang H J Invest Surg; 2020 Jul; 33(6):576-583. PubMed ID: 30913929 [No Abstract] [Full Text] [Related]
19. Dexmedetomidine protects against high mobility group box 1-induced cellular injury by inhibiting pyroptosis. Ji X; Guo Y; Zhou G; Wang Y; Zhang J; Wang Z; Wang Q Cell Biol Int; 2019 Jun; 43(6):651-657. PubMed ID: 30958608 [TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling. Zhao L; Zhai M; Yang X; Guo H; Cao Y; Wang D; Li P; Liu C J Cell Mol Med; 2019 Dec; 23(12):8173-8183. PubMed ID: 31625681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]